Global Analgesics Market is valued at USD 52.14 Billion in 2021and is expected to reach USD 74.35 Billion by 2028 with a CAGR of 5.2% over the forecast period.
Global Analgesics Market: Global Size, Trends, Competitive, And Historical & Forecast Analysis, 2021-2028: Increasing prevalence of chronic diseases, rising geriatric population, and a growing number of clinical studies are some of the major factors driving the growth of the Global Analgesics Market.
Analgesics, also known as painkillers, are used to reduce and treat pain in the body. Analgesics are theoretically particular from sedatives, which momentarily lessen, and in certain occasions, dispose of, sensation, analgesia and anesthesia are neurophysiologically covered and subsequently different medications make both pain-relieving and sedative impacts. Analgesics are drugs implied for pain control fundamentally. The drugs work on the CNS and peripheral nervous system for decreasing or impeding pain sensitivity. There are likewise analgesics that work by preventing the creation of pain interceding synthetic substances in the body. Generally utilized for the therapy of mild to acute pain credited to several medical conditions, wounds, medical procedures and terminal issues, analgesics have controlled the pain management for beyond quite a few years. These prescriptions have given clinical experts with an effective option to reduce pain and help progress quality of life for patients.
The Covid-19 pandemic has shown a positive impact on the growth of the global analgesics market. The Covid-19 epidemic has strained the world's health care systems and increased the need for advanced hospitals. The outbreak of Covid -19 infection spread increased demand for painkillers such as paracetamol and boosted the market growth.
The global analgesics market is segmented on the basis of the type, distribution channel, route of administration, drug type, application, and region & country level. On the basis of type, the global analgesics market is segmented into opioids and non-opioids. By distribution channel, the global analgesics market is segmented into retail pharmacies, drug stores, and hospital pharmacies. By route of administration, the global analgesics market is segmented into intravenous, rectal, oral, transdermal, and topical. By drug type, the global analgesics market is segmented into OTC analgesics and prescription analgesics.
Some major key players for the global analgesics market report cover prominent players like
On February 9th, 2022; the US Food and Drug Administration taken new steps aimed at promoting the development of opioids addiction options for managing acute pain and reducing opioids exposure, and preventing new addictions. The agency issued draft guidelines to provide recommendations to companies that developed non-opioid analgesics for acute pain lasting up to 30 days, specifically in response to certain types of tissue injuries, such as trauma or surgery.
On January 7th, 2020; Vapogenix, a clinical-stage organization developed another class of effective non-opioids, without lidocaine analgesics, reported its management team will hold collaborating and investor meetings. Vapogenix is centered around changing the dependence on opioids for the treatment of a wide range of topical pain. The organization's remarkable portfolio of analgesics are novel, protected formulations of volatile anesthetics (VAs) for patients experiencing acute and chronic pain from wounds, skin ulcers, consumption, and provocative skin and joint disease.
One of the major factors driving the growth of the global analgesics market is the increasing prevalence of chronic diseases. Analgesic drugs are utilized to treat and reduce chronic or extreme pain caused by an assortment of clinical issues. Also, the prevalence of infections like cancer has expanded, expanding the quantity of individuals who suffer from chronic pain. Chronic disease has risk factors such as unhealthy diet, tobacco use, and physical inactivity. And moderate risk factors, such as elevated blood lipids, diabetes, hypertension, and overweight / obesity. Therefore, these factors are increasing the prevalence of chronic diseases further drive the global analgesics market. For example; according to the National Health Council (NIH), chronic diseases influence around 133 million Americans, addressing over 40% of the absolute populace of this country. By 2020, that number is projected to develop to an expected 157 million, with 81 million having various conditions.
In addition, the rising geriatric population is also boosting the growth of the global analgesics market. The elderly population suffers from chronic diseases such as heart disease, cancer, arthritis, chronic pain, and aches and pains. The maturing lung is dependent upon natural changes which make it more vulnerable to infection. In addition, the elderly population suffers from the disease due to diastolic dysfunction and age-related blood vessel stiffness which further increases the business demand. Therefore, the increasing geriatric population is expected to fuel the market growth over the forecast period. For instance; according to United Nation; in 2019, about 703 million people aged 65 in the world. The number of geriatric people is projected to double to 1.5 billion by 2050. Thus, at a significant rate of population aging, the frequency of analgesics in the aging population will increase in the near future.
Moreover, the growing number of clinical studies is another factor supplementing the market growth. The increase in the number of clinical studies to evaluate the safety and efficacy of a wide range of therapeutic drugs drives the growth of the analgesic market. In April 2019, WCG, a US-based drugs organization acquired Analgesic Solutions, LLC. WCG's freshest obtaining means to further develop test sensitivity in clinical preliminaries, through advising, data science, novel tools, innovation, and specific training. Analgesic Solutions, LLC is a US-based drug organization that works on the improvement of new pain medications.
However, the high cost associated with analgesics is may hinder the growth of the global analgesics market. In spite of that, an increasing number of strategic collaborations, and a rising number of research and development activities can offer more opportunities in the global analgesics market.
Geographically, North America is expected to dominate the global analgesics market within the forecast period due to the increasing prevalence of chronic and acute pain patients, rising demand for analgesic products, and development in R&D activities in the healthcare sector in this region. The increasing prevalence of chronic and acute pain patients is one of the major factors driving the growth of the market. For example; according to U.S. Centers for Disease Control and Prevention National Center for Health Statistics; in 2019, around 20% of the USA populace experiences chronic pain in the USA.
The Asia Pacific is expected to be the fastest-growing region in the global analgesics market due to the increasing geriatric population and growing development of healthcare infrastructure in this region. For example; according to United Nations Population Fund; by 2050, one of every four individuals in Asia and the Pacific will be over 60 years of age.
|2018 - 2021
|2021 - 2028
|Market Size in 2021:
|USD 52.14 Billion
|Base year considered
|Forecast Period CAGR %:
|Market Size Expected in 2028:
|USD 74.35 Billion
|Tables, Charts & Figures:
|Novartis AG, GlaxoSmithKline PLC, Pfizer Inc., Reckitt Benckiser, Endo Pharmaceuticals, Eli Lily and Company, Sanofi, Bristol Myer’s Squibb, Johnson & Johnson, Bayer AG, and others.
|By Type, By Distribution Channel, By Route of Administration, By Drug Type
|North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us firstname.lastname@example.orgJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®